Cervantes-Gomez, F., Lamothe, B., Woyach, J. A., Wierda, W. G., Keating, M. J., Balakrishnan, K., & Gandhi, V. (2015). Pharmacological and protein profiling suggest venetoclax (ABT-199) as optimal partner with ibrutinib in chronic lymphocytic leukemia. Clin Cancer Res.

Cervantes-Gomez, Fabiola, Betty Lamothe, Jennifer A. Woyach, William G. Wierda, Michael J. Keating, Kumudha Balakrishnan, and Varsha Gandhi. "Pharmacological and Protein Profiling Suggest Venetoclax (ABT-199) As Optimal Partner With Ibrutinib in Chronic Lymphocytic Leukemia." Clin Cancer Res 2015.

Cervantes-Gomez, Fabiola, et al. "Pharmacological and Protein Profiling Suggest Venetoclax (ABT-199) As Optimal Partner With Ibrutinib in Chronic Lymphocytic Leukemia." Clin Cancer Res 2015.